Manitowoc Heads Into Earnings With Bulls in Control of Options

The analyst community is far more cautious than the options market implies. The most recent available consensus — now several months old and flagged as stale — pegs the mean price target at $10.50, roughly 26% below the current price. Barclays has maintained an Underweight rating throughout, trimming its target to $11 in early April. Wells Fargo carries the same Underweight view, with a $10 target. The only neutral voices, Baird and UBS, have both trimmed targets repeatedly since mid-2025. No major firm has recently moved in a positive direction. That puts the stock trading materially through what its coverage universe considers fair value, making the earnings quality and forward guidance the fulcrum for any re-rating argument.

Short interest offers little additional drama. At 3.3% of the free float — and drifting lower over the past month — bears have been trimming, not adding. Borrowing costs have eased sharply too, falling nearly 69% on the week to 0.82%. Availability is exceptionally loose at over 6,000% of short interest, meaning there is no meaningful constraint on either side of the trade. The ORTEX short score of 38 is unremarkable and has barely moved in two weeks. This is not a squeeze setup or a heavily crowded short — the real debate is fundamental.

The print will test whether Manitowoc can justify a share price that now sits roughly a third above where its analysts think it belongs, and whether forward guidance on the crane and lifting cycle can shift that consensus in a stock where options traders have already decided the answer is yes.